MLchartDataset catalogue

bispecific antibody QLF3108

Term · Oncology and biomedicine · MLC-T-ONC-012041

A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody QLF3108 targets and binds to the two antigens expressed on T cells and tumor cells respectively. This may activate T cells to kill tumor cells expressing the specific tumor-associated antigen (TAA).

Table 1. Record
IdentifierMLC-T-ONC-012041
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012041",
  "term": "bispecific antibody QLF3108",
  "field": "Oncology and biomedicine",
  "definition": "A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody QLF3108 targets and binds to the two antigens expressed on T cells and tumor cells respectively. This may activate T cells to kill tumor cells expressing the specific tumor-associated antigen (TAA).",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bispecific-antibody-qlf3108/"
}

Record 3,618 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.